About DiscoverX
DiscoverX is a company based in Birmingham (United Kingdom) founded in 2000 was acquired by Eurofins Scientific in July 2017. DiscoverX has raised $13.4 million across 3 funding rounds from investors including Eurofins Scientific. DiscoverX has completed 1 acquisition, including BioSeek. DiscoverX offers products and services including Bioassay Kits, Recombinant Helicases, and Checkpoint Agonist Antibody Assays. DiscoverX operates in a competitive market with competitors including Kiyatec, Cellply, Lucid Scientific, CytoTronics and Saguaro, among others.
- Headquarter Birmingham, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Discoverx Corporation, Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.4 M (USD)
in 3 rounds
-
Latest Funding Round
$8 M (USD), Series B
Oct 27, 2010
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Eurofins Scientific
(Jul 31, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DiscoverX
DiscoverX offers a comprehensive portfolio of products and services, including Bioassay Kits, Recombinant Helicases, and Checkpoint Agonist Antibody Assays.
Kits for accelerating development of obesity and diabetes drugs.
Proteins for hit finding and therapeutic innovation in DNA and RNA.
Assays to detect potential in antibody candidates for checkpoint receptors.
People of DiscoverX
Unlock access to complete
Funding Insights of DiscoverX
DiscoverX has successfully raised a total of $13.4M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $8 million completed in October 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DiscoverX
DiscoverX has secured backing from 1 investor. Prominent investors backing the company include Eurofins Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Laboratory testing and contract research services are provided globally.
|
Locked | Locked | Locked |
Investor details for DiscoverX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DiscoverX
DiscoverX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BioSeek.
Investment portfolio details for DiscoverX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of drug discovery services
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for DiscoverX
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - DiscoverX
Detailed financials for DiscoverX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Discoverx Comparisons
Peer comparison for DiscoverX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DiscoverX
DiscoverX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kiyatec, Cellply, Lucid Scientific, CytoTronics and Saguaro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| Locked | Locked | Locked |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| Locked | Locked | Locked |
3D cell culture products are developed for drug discovery applications.
|
Detailed competitors of DiscoverX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Discoverx
Complete news archive for DiscoverX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DiscoverX
DiscoverX was founded in 2000 and raised its 1st funding round 7 years after it was founded.
DiscoverX is headquartered in Birmingham, United Kingdom. It is registered at Birmingham, England, United Kingdom.
DiscoverX is a funded company, having raised a total of $13.4M across 3 funding rounds to date.
Reagent and complete cell-based assay kits are developed, manufactured, and marketed by DiscoverX, along with profiling and screening services for drug discovery. The BioMAP platform, which simulates human cell types and tissue interactions in disease states, is utilized to support screening, lead optimization, and SAR campaigns. Founded in 2000, operations are based in the biotechnology sector in Birmingham, United Kingdom.
DiscoverX's top competitors include CytoTronics, Kiyatec and Remedy Plan.
DiscoverX offers Bioassay Kits, Recombinant Helicases, and Checkpoint Agonist Antibody Assays.
DiscoverX has made 1 acquisition, including BioSeek.
DiscoverX has 1 investor. Key investors include Eurofins Scientific.